Literature DB >> 21893220

A girl with an atypical form of ataxia telangiectasia and an additional de novo 3.14 Mb microduplication in region 19q12.

Oliver Bartsch1, Detlev Schindler, Vera Beyer, Stefan Gesk, Ruben van't Slot, Isa Feddersen, Arjan Buijs, Nicolaas G J Jaspers, Reiner Siebert, Thomas Haaf, Martin Poot.   

Abstract

A 9-year-old girl born to healthy parents showed manifestations suggestive of ataxia telangiectasia (AT), such as short stature, sudden short bouts of horizontal and rotary nystagmus, a weak and dysarthric voice, rolling gait, unstable posture, and atactic movements. She did not show several cardinal features typical of AT such as frequent, severe infections of the respiratory tract. In contrast, she showed symptoms not generally related to AT, including microcephaly, profound motor and mental retardation, small hands and feet, severely and progressively reduced muscle tone with slackly protruding abdomen and undue drooling, excess fat on her upper arms, and severe oligoarthritis. A cranial MRI showed no cerebellar hypoplasia and other abnormalities. In peripheral blood samples she carried a de novo duplication of 3.14 Mb in chromosomal region 19q12 containing six annotated genes, UQCRFS1, VSTM2B, POP4, PLEKHF1, CCNE1, and ZNF536, and a de novo mosaic inversion 14q11q32 (96% of metaphases). In a saliva-derived DNA sample only the duplication in 19q12 was detected, suggesting that the rearrangements in blood lymphocytes were acquired. These findings reinforced the suspicion that she had AT. AT was confirmed by strongly elevated serum AFP levels, cellular radiosensitivity and two inherited mutations in the ATM gene (c.510_511delGT; paternal origin and c.2922-50_2940del69; maternal origin). This case suggest that a defective ATM-dependent DNA damage response may entail additional stochastic genomic rearrangements. Screening for genomic rearrangements appears indicated in patients suspected of defective DNA damage responses.
Copyright © 2011 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21893220     DOI: 10.1016/j.ejmg.2011.08.001

Source DB:  PubMed          Journal:  Eur J Med Genet        ISSN: 1769-7212            Impact factor:   2.708


  6 in total

1.  Adding Insult to Injury, Complexity to Intricacy.

Authors:  Martin Poot
Journal:  Mol Syndromol       Date:  2017-06-09

2.  Novel biallelic ATM mutations coexist with a mosaic form of triple X syndrome in an 11-year-old girl at remission after T cell acute leukemia.

Authors:  Svetlana O Sharapova; Alena V Valochnik; Irina E Guryanova; Inga S Sakovich; Olga V Aleinikova
Journal:  Immunogenetics       Date:  2018-02-28       Impact factor: 2.846

3.  Variant ataxia telangiectasia: clinical and molecular findings and evaluation of radiosensitive phenotypes in a patient and relatives.

Authors:  Kathleen Claes; Julie Depuydt; A Malcolm R Taylor; James I Last; Annelot Baert; Peter Schietecatte; Veerle Vandersickel; Bruce Poppe; Kim De Leeneer; Marc D'Hooghe; Anne Vral
Journal:  Neuromolecular Med       Date:  2013-04-30       Impact factor: 3.843

4.  Zimmermann-Laband syndrome: Clinical and cytogenetic study in two related patients.

Authors:  Sadegh Shirian; Hassan Shahabinejad; Abolfazl Saeedzadeh; Khosrow Daneshbod; Hengameh Khosropanah; Mostafa Mortazavi; Yahya Daneshbod
Journal:  J Clin Exp Dent       Date:  2019-05-01

5.  Computational methods to detect conserved non-genic elements in phylogenetically isolated genomes: application to zebrafish.

Authors:  Michael Hiller; Saatvik Agarwal; James H Notwell; Ravi Parikh; Harendra Guturu; Aaron M Wenger; Gill Bejerano
Journal:  Nucleic Acids Res       Date:  2013-06-27       Impact factor: 16.971

6.  Identification of brain-enriched proteins in the cerebrospinal fluid proteome by LC-MS/MS profiling and mining of the Human Protein Atlas.

Authors:  Ilijana Begcevic; Davor Brinc; Andrei P Drabovich; Ihor Batruch; Eleftherios P Diamandis
Journal:  Clin Proteomics       Date:  2016-05-15       Impact factor: 3.988

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.